Limits...
The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer.

Blood PA, Pickles T - Radiat Oncol (2007)

Bottom Line: The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer.Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment.This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.

View Article: PubMed Central - HTML - PubMed

Affiliation: Radiation Oncology, BC Cancer Agency and University of British Columbia, Victoria, BC, Canada. pblood@bccancer.bc.ca

ABSTRACT
Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer. This study used the provincial cancer registry in British Columbia, Canada, to determine median non-prostate cancer survival for men who were aged 75 to 82 years at start of radiation treatment. Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment. This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.

Show MeSH

Related in: MedlinePlus

Median survival at age of starting radiation treatment. The top line is the median survival from non-prostate cancer death for men treated with radiation treatment. The bottom line is the median survival at the same age for the male population of British Columbia, Canada.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC1887532&req=5

Figure 2: Median survival at age of starting radiation treatment. The top line is the median survival from non-prostate cancer death for men treated with radiation treatment. The bottom line is the median survival at the same age for the male population of British Columbia, Canada.

Mentions: Figure 2 shows the K-M median non-prostate cancer survival by age at start of radiation treatment and the median all-cause survival for all men of the same age in the BC population. The median non-prostate cancer survival is greater than 10 years for men aged up to 80 years at start of radiation treatment. The non-prostate cancer survival of men selected for radiation treatment is consistently longer than the all-cause survival of men of the same age in the BC population.


The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer.

Blood PA, Pickles T - Radiat Oncol (2007)

Median survival at age of starting radiation treatment. The top line is the median survival from non-prostate cancer death for men treated with radiation treatment. The bottom line is the median survival at the same age for the male population of British Columbia, Canada.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC1887532&req=5

Figure 2: Median survival at age of starting radiation treatment. The top line is the median survival from non-prostate cancer death for men treated with radiation treatment. The bottom line is the median survival at the same age for the male population of British Columbia, Canada.
Mentions: Figure 2 shows the K-M median non-prostate cancer survival by age at start of radiation treatment and the median all-cause survival for all men of the same age in the BC population. The median non-prostate cancer survival is greater than 10 years for men aged up to 80 years at start of radiation treatment. The non-prostate cancer survival of men selected for radiation treatment is consistently longer than the all-cause survival of men of the same age in the BC population.

Bottom Line: The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer.Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment.This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.

View Article: PubMed Central - HTML - PubMed

Affiliation: Radiation Oncology, BC Cancer Agency and University of British Columbia, Victoria, BC, Canada. pblood@bccancer.bc.ca

ABSTRACT
Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer. This study used the provincial cancer registry in British Columbia, Canada, to determine median non-prostate cancer survival for men who were aged 75 to 82 years at start of radiation treatment. Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment. This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.

Show MeSH
Related in: MedlinePlus